global nuclear medicine equipment market is estimated to reach $2.64 billion by 2022, from $2.01 billion in 2015, registering a CAGR of 3.9% from 2016 to 2022
Rising cases of chronic diseases such as cancer, cardiac and neurological disorders, increasing awareness about the early diagnosis of disease and technological advancements have boosted the growth of the medical imaging systems market. Besides, rise in geriatric population, increasing expenditure on healthcare and growing demand for imaging system procedures are expected to further fuel the market growth. However, high cost of the imaging systems coupled with unfavorable reimbursement initiatives have restricted the growth of the market in developing regions.
Covid-19 Scenario
During the Covid-19 pandemic, there was a decline in conventional nuclear imaging procedures in electric surgery for cardiovascular diseases and the diagnosis of different types of cancers. This led to reduced demand for various types of equipment such as SPECT.
Hospitals and healthcare organizations across the world postponed the non-elective surgeries during the pandemic to focus on treatment of huge number of patients infected with coronavirus. This consequently, reduced the demand for nuclear medicine equipment.
The single-photon emission computed tomography (SPECT) segment to maintain its dominance throughout the forecast period
Based on product, the single-photon emission computed tomography (SPECT) segment accounted for the highest market share in 2020, contributing to more than half of the global nuclear medicine equipment market, and is estimated to maintain its dominance throughout the forecast period. This is attributed to rise in prevalence of cancer across the world. However, the positron emission tomography (PET) segment is projected to manifest the fastest CAGR of 3.6% from 2021 to 2030. This is due to rise in usage to enhance the accuracy of nuclear medicine imaging in the field of clinical oncology and diagnosis of brain tumor.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1828
The hospitals segment to continue its leadership status by 2030
Based on end user, the hospitals segment held the highest share in 2020, accounting for more than half of the global nuclear medicine equipment market, and is projected to continue its leadership status by 2030. This is attributed to rise in the prevalence of cancer and the surge in demand for nuclear medicine equipment in hospitals. However, the academic and research institutes segment is estimated to witness the highest CAGR of 6.1% from 2021 to 2030. This is due to increase in research and development activities toward nuclear medicines.
North America to continue its lead position by 2030
Based on region, North America contributed to the highest market share in terms of revenue in 2020, accounting for around two-fifths of the global live chat software market, and is projected to continue its lead position by 2030. This is attributed to well-established healthcare infrastructure and the presence of major key players in the market. However, Asia-Pacific is estimated to witness the largest CAGR of 4.4% during the forecast period, owing to increase in prevalence of cancer & other chronic diseases, rise in awareness about early diagnosis of cancer, and untapped potential in the region.
Leading Market Players
Simen Healthineers
Fujifilm Holdings
Canon Inc
Digirad Corporation
Mediso Medical Imaging Systems
SurgicEye GmbH
General Electric Company
Koninklijke Philips N.V.
Bozlu Holding
Nuerosoft Medical Systems
We also Offers Regional and Country Reports-
Japan Nuclear Medicine Equipment Market
South Korea Nuclear Medicine Equipment Market
Singapore Nuclear Medicine Equipment Market
China Nuclear Medicine Equipment Market
Indonesia Nuclear Medicine Equipment Market
Australia Nuclear Medicine Equipment Market
Taiwan Nuclear Medicine Equipment Market
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of ‘Market Research Reports’ and ‘Business Intelligence Solutions.’ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
